Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 16 of 39

  1. Henagliflozin Proline Tablets treatment

    The First People's Hospital of Lianyungang

    Diabetes Type 2

    approved small molecule active

    1 trial

  2. Hepatitis B vaccine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Hepatitis B Vaccination, HIV

    approved mab active

    1 trial

  3. High-dosage SARS-CoV-2 vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  4. High-dose anrikefon

    The First People's Hospital of Lianyungang

    Laparoscopic Surgery

    approved small molecule active

    2 trials

  5. Honghe Fujie lotion

    The First People's Hospital of Lianyungang

    Bacterial Vaginitis

    approved small molecule active

    1 trial

  6. Hydrocortisone Acetate 1% Ointment

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Sore Throat, Cough, Hoarseness

    approved small molecule active

    1 trial

  7. Hydroxychloroquine Sulfate

    The First People's Hospital of Lianyungang

    Primary IgA Nephropathy

    approved small molecule completed

    1 trial

  8. Hydroxychloroquine Sulfate 200 Mg Tablet

    The First People's Hospital of Lianyungang

    Atrial Fibrillation

    approved small molecule active

    1 trial

  9. Hylenex

    HALOZYME THERAPEUTICS, INC.

    Healthy

    approved small molecule completed

    2 trials

  10. Hyperbaric bupivacaine+Sufentanil

    Lxo Ireland Designated Activity Company

    Anesthesia; Functional

    approved small molecule completed

    1 trial

  11. Hypo-osmolar ORS

    United Therapeutics Europe Ltd

    Diarrhoea

    approved small molecule completed

    1 trial

  12. I4V-MC-JAJA

    Eli Lilly Co.

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  13. I6T-MC-AMCA

    Eli Lilly Co.

    severely active ulcerative colitis (US) and CD (Crohn’s disease)

    approved small molecule active

    1 trial

  14. ICD Ablation plus VT-ablation

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Ventricular

    approved other completed

    1 trial

  15. ICI22/00054

    The George Institute

    patients who are requested a colonoscopy for any indication and are under antiplatelet treatment (except ASA) or anticoagulant treatment

    approved small molecule active

    1 trial

  16. ICS+LABA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchiectasis

    approved small molecule completed

    1 trial

  17. ICS/LABA

    The First People's Hospital of Lianyungang

    Asthma

    approved small molecule active

    1 trial

  18. IDEA

    CERO THERAPEUTICS HOLDINGS, INC.

    Ulcerative Colitis

    approved small molecule active

    1 trial

  19. IIBSP-FAS-2020-120

    The George Institute

    Complicated acute appendicitis

    approved small molecule active

    1 trial

  20. IIBSP-HOP-2021-01

    The George Institute

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  21. IIBSP-OXI-2022-124

    The George Institute

    Borderline Personality Disorder.

    approved small molecule active

    1 trial

  22. IIV4 and PPV23

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza, Human

    approved mab completed

    1 trial

  23. IJG-PREMI-2024

    The George Institute

    Migraine

    approved small molecule active

    1 trial

  24. ILUVIEN

    ANI PHARMACEUTICALS INC

    Chronic Diabetic Macular Edema

    approved small molecule completed

    1 trial

  25. ILUVIEN 0.19 MG

    ANI PHARMACEUTICALS INC

    Diabetic Macular Edema (DME)

    approved small molecule completed

    1 trial

  26. IM011-1130

    Bristol-Myers Squibb Australia Pty Ltd

    Moderate to Severe Plaque Psoriasis

    approved small molecule active

    1 trial

  27. IMATINIB for Chronic myeloid leukaemia

    Disc Medicine

    Chronic myeloid leukaemia

    approved small molecule active

    1 trial

  28. INDOCYANINE GREEN

    Disc Medicine

    cervical cancer stage I-IIA

    approved small molecule active

    1 trial

  29. INDOCYANINE GREEN

    The George Institute

    Patients with liver tumors that will undergo minimally invasive liver surgery

    approved small molecule active

    1 trial

  30. INDV-6000-406

    Indivior Pty Ltd

    Opioid Use Disorder

    approved small molecule active

    1 trial

  31. INFLIXIMAB, INFLIXIMAB

    Istituto Gentili S.r.l.

    Inflammatory Bowel Disease

    approved small molecule active

    1 trial

  32. INFLUENZA for Influenza, Immunity against inf…

    The George Institute

    Influenza, Immunity against influenza

    approved small molecule active

    1 trial

  33. INSULIN GLARGINE

    Sanofi-aventis Healthcare Pty Ltd

    Diabetes mellitus II

    approved small molecule active

    1 trial

  34. INSULIN GLARGINE (HOE901)

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  35. INTENSIFY SZ

    Disc Medicine

    schizophrenia, schizoaffective disorder, schizophrenifom disorder

    approved small molecule active

    1 trial

  36. IODEX® balm

    GlaxoSmithKline

    Pain

    approved small molecule completed

    1 trial

  37. IPTACOPAN HYDROCHLORIDE, IPTACOPAN

    Novartis Pharmaceuticals

    C3 Glomerulopathy or idiopathic immune-complex membranoproliferative glomerulonephritis

    approved small molecule active

    1 trial

  38. IRB202101979 -A

    BRIGHT MINDS BIOSCIENCES INC.

    Pneumonia

    approved small molecule terminated

    1 trial

  39. IRON OXIDE (E172)

    Disc Medicine

    Glioblastoma

    approved small molecule active

    1 trial

  40. ITALIC-RCC

    Fondazione Telethon ETS

    metastatic or locally advanced renal cell carcinoma

    approved small molecule active

    1 trial

  41. IV Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Chronic Pelvic Pain

    approved small molecule active

    1 trial

  42. IV ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Arthroscopic Knee Surgery

    approved small molecule completed

    1 trial

  43. IV ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  44. IV morphine sulfate

    Pacira Ireland Limited

    Bowel Obstruction

    approved small molecule terminated

    2 trials

  45. IV morphine sulfate or Sponsor-approved equivalent

    Pacira Ireland Limited

    Bowel Obstruction

    approved small molecule terminated

    1 trial

  46. IV morphine sulfate or Sponsor-approved equivalent

    Pacira Ireland Limited

    Retraction of Colostomy

    approved small molecule completed

    1 trial

  47. IVC

    The First People's Hospital of Lianyungang

    Proliferative Diabetic Retinopathy

    approved small molecule active

    1 trial

  48. IXCHIQ

    Ars Pharmaceuticals Irl Limited

    Chikungunya Virus Infection

    approved mab active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.